Early Recovery After Surgery (ERAS)/Prehabilitation - Randomized Controlled Trial on the Implementation of ERAS/prehabilitation in Elective Reconstructive Shoulder Surgery

ConditionRotator Cuff
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorProf. Arasch Wafaisade

About this trial

The aim of this randomized controlled trial is to investigate whether the intervention can improve the clinical outcome and patient satisfaction in elective reconstructive shoulder surgeries. The study participants are adults with a diagnosed rotator cuff tear for which surgical treatment is planned. This main question is to be answered by the study:

• Does prehabilitation before elective shoulder surgeries lead to an improvement in postoperative outcomes and patient satisfaction compared to the control group?

The control group receives standard information about the hospital stay, while the intervention group undergoes the prehabilitation program in the approximately 6 weeks prior to surgery. This program includes:

* Information on the condition and pain management * Recommendations for behavior modification * A home exercise program Primary endpoint is the Western Ontario Rotator Cuff Index (WORC). The assessments are conducted at four time points: at study enrollment, immediately before surgery, and at 6, 12, and 24 months after surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with a traumatic or degenerative rupture of the rotator cuff with whom surgical treatment has been discussed in the shoulder clinic.

Disqualifiers

Pre-existing fracture of the upper arm or shoulder girdle, rheumatic arthritis/fibromyalgia, additional findings in the shoulder joint (instability, frozen shoulder), neurological disease, cognitive or speech impairment

Trial design

Design model

Parallel

Treatments tested in this trial

  • Prehabilitation

    Procedure/Surgery

    The waiting time until the operation is about 6 weeks. The intervention is carried out during this time: The intervention group receives a brochure with an evidence-based exercise program for the shoulder and shoulder girdle. The brochure contains pages in which the patient documents how the exercises are carried out. The exercise program is supplemented by information in the form of a video/Power Point presentation on: Anatomy/function, pain management, hospitalization and subsequent rehabilitation. After 2 and after 4 weeks, the physiotherapist who has explained the exercise program will contact you by telephone/zoom.

  • Control

    Procedure/Surgery

    The control group receives a leaflet with general information for the period up to the operation (e.g. buy water-resistant plasters, arrange post-op physiotherapy appointments).

Treatment groups

84 Participants
are divided into 2 treatment groups
Group A: Prehabilitation-GroupActive comparator 1 intervention
Group B: Control-GroupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Western Ontario Rotator Cuff Index (WORC)

The WORC Index is a self-administered questionnaire designed to assess the quality of life in individuals with rotator cuff tendinopathy. It consists of 21 items across five domains: Physical Symptoms, Sports and Recreation, Work, Lifestyle, and Emotions. Each item is rated on a visual analogue scale (VAS) from 0 to 100. The total score ranges from 0 to 2100, which can be converted to a percentage for easier interpretation. A higher percentage indicates better shoulder function. The WORC Index is widely used in clinical settings to evaluate symptoms, functional limitations, and treatment outcomes.

Time frame
Inclusion in the study (T0), before surgery (T1); 6 months (T2), 12 months (T3) and 24 months (T4) after surgery

Secondary outcomes

1

Patient survey on Treatment satisfaction and willingness to recommend

A brief, self-designed questionnaire was developed to measure overall satisfaction through patient satisfaction and willingness to recommend. It utilizes a 6-point Likert scale for responses.

Time frame
before surgery (T1); 6 months (T2), 12 months (T3) and 24 months (T4) after surgery
2

EQ-5D quality of life questionnaire

The EQ-5D is a standardized questionnaire developed by the EuroQol Research Foundation to measure health-related quality of life. It consists of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each rated on a scale of severity. Additionally, it includes a visual analogue scale (EQ VAS) for the patient's self-rated health. The EQ-5D is widely used in clinical studies, health economics, and routine care to assess and compare quality of life across different health conditions and populations. It provides a simple, reliable, and internationally recognized tool for evaluating overall health status.

Time frame
Inclusion in the study (T0), before surgery (T1); 6 months (T2), 12 months (T3) and 24 months (T4) after surgery
3

Constant Murely score for self-evaluation

The Constant-Murley Score for self-evaluation, adapted by Boehm et al. in 2003, is a modified version of the original Constant-Murley Score that allows patients to independently assess their shoulder function. It includes parameters such as pain, activities of daily living, range of motion, and strength, scored on a standardized scale. This self-assessment tool provides a reliable and practical method for patients to evaluate their shoulder condition, enabling its use in clinical research and routine monitoring of treatment outcomes.

Time frame
Inclusion in the study (T0), before surgery (T1); 6 months (T2), 12 months (T3) and 24 months (T4) after surgery
4

Subjective shoulder value

The Subjective Shoulder Value (SSV) is a patient-reported numeric scale that reflects the subjective assessment of shoulder function. Patients rate their current shoulder function as a percentage compared to a normal, healthy shoulder, with 0% representing no function and 100% representing full, unrestricted function. Developed by Gilbart and Gerber in 2007, the SSV is a simple, quick, and reliable tool for evaluating subjective shoulder functionality. It is widely used in clinical studies and daily practice to monitor progress and document outcomes in shoulder conditions.

Time frame
Inclusion in the study (T0), before surgery (T1); 6 months (T2), 12 months (T3) and 24 months (T4) after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Prof. Arasch Wafaisade

Lead sponsor

University of Witten/Herdecke

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: